VENOM-DERIVED PEPTIDE AND ANTIBODY-PEPTIDE FUSION: A PROMISING APPROACH FOR ANALGESIC DEVELOPMENT IN OSTEOARTHRITIS Osteoarthritis (OA) is a multifactorial joint disease characterized by cartilage degeneration, inflammation, and chronic pain. Pain is the most disabling symptom of OA, and although several analgesics are available, they often cause serious adverse effects, highlighting an urgent need for safer and more effective analgesic molecules. Elevated levels of advanced glycation end-products from glycated collagen (GC) contribute to OA progression and pain by disrupting extracellular matrix integrity and inducing oxidative stress and inflammatory responses. GC activates joint cells, such as chondrocytes and macrophages, promoting cytokine release and matrix degradation that may sensitize sensory neurons and amplify nociceptive signaling. We developed a cell culture model combining a GC matrix and sensory-like neurons, showing that GC directly sensitizes neuronal cells by increasing substance P release and impairing neurite outgrowth. Using a bioactive peptide (Lop) from caterpillar bristles, we demonstrated potential antinociceptive and neuroprotective effects in GC-sensitized neurons. To optimize its pharmacological properties, an antibody-peptide fusion (Lopb) was generated to enhance stability and solubility while preserving biological activity.
Osteoarthritis and Cartilage · 2026-04 · 34 · S376
DOI: 10.1016/j.joca.2026.01.545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Osteoarthritis and Cartilage, 2026-04. Verfasst von Michelle C. Bufalo und 14 weiteren Autor:innen.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bufalo, M. C., Dallazen, J. L., Buri, M. V., Pereira, C. D., Oliveira, D. S., ALVAREZ-FLORES, M. P., Souza, M. M. D., Behr, B. M., Vigerelli, H., Batista, C. M., Manieri, T. M., Picolo, G., Moro, A. M., Zambelli, V. O., & Chudzinski-Tavassi, A. M. (2026). VENOM-DERIVED PEPTIDE AND ANTIBODY-PEPTIDE FUSION: A PROMISING APPROACH FOR ANALGESIC DEVELOPMENT IN OSTEOARTHRITIS Osteoarthritis (OA) is a multifactorial joint disease characterized by cartilage degeneration, inflammation, and chronic pain. Pain is the most disabling symptom of OA, and although several analgesics are available, they often cause serious adverse effects, highlighting an urgent need for safer and more effective analgesic molecules. Elevated levels of advanced glycation end-products from glycated collagen (GC) contribute to OA progression and pain by disrupting extracellular ma…. Osteoarthritis and Cartilage, 34, S376. https://doi.org/10.1016/j.joca.2026.01.545
Vancouver
Bufalo MC, Dallazen JL, Buri MV, Pereira CD, Oliveira DS, ALVAREZ-FLORES MP, et al. VENOM-DERIVED PEPTIDE AND ANTIBODY-PEPTIDE FUSION: A PROMISING APPROACH FOR ANALGESIC DEVELOPMENT IN OSTEOARTHRITIS Osteoarthritis (OA) is a multifactorial joint disease characterized by cartilage degeneration, inflammation, and chronic pain. Pain is the most disabling symptom of OA, and although several analgesics are available, they often cause serious adverse effects, highlighting an urgent need for safer and more effective analgesic molecules. Elevated levels of advanced glycation end-products from glycated collagen (GC) contribute to OA progression and pain by disrupting extracellular ma…. Osteoarthritis and Cartilage. 2026;34:S376. doi:10.1016/j.joca.2026.01.545
BibTeX
@article{Bufalo2026,
author = {Bufalo, Michelle C. and Dallazen, Jorge Luiz and Buri, Marcus V. and Pereira, Carlos d. and Oliveira, Douglas S. and ALVAREZ-FLORES, MIRYAM PAOLA and Souza, Marcelo M. de and Behr, Barbara M. and Vigerelli, Hugo and Batista, Cassiano M. and Manieri, Tania M. and Picolo, Gisele and Moro, Ana M. and Zambelli, Vanessa O. and Chudzinski-Tavassi, Ana M.},
title = {VENOM-DERIVED PEPTIDE AND ANTIBODY-PEPTIDE FUSION: A PROMISING APPROACH FOR ANALGESIC DEVELOPMENT IN OSTEOARTHRITIS Osteoarthritis (OA) is a multifactorial joint disease characterized by cartilage degeneration, inflammation, and chronic pain. Pain is the most disabling symptom of OA, and although several analgesics are available, they often cause serious adverse effects, highlighting an urgent need for safer and more effective analgesic molecules. Elevated levels of advanced glycation end-products from glycated collagen (GC) contribute to OA progression and pain by disrupting extracellular ma…},
journal = {Osteoarthritis and Cartilage},
year = {2026},
volume = {34},
pages = {S376},
doi = {10.1016/j.joca.2026.01.545}
}
EUVIMED